Previous Page  46 / 62 Next Page
Information
Show Menu
Previous Page 46 / 62 Next Page
Page Background

CheckMate 032: Nivolumab ± Ipilimumab in Advanced SCLC

ORR by Subgroups – Pooled Cohorts

1 … 41 42 43 44 45 46 47 48 49 50 51 52 … 62